BioTech Leads

B2B Lead Generation for BioTech Companies That Raised in the Last 7 Days

Most B2B lead generation for BioTech means hiring an agency, signing a monthly retainer, and waiting a quarter for the first qualified meeting. Fundraise Insider flips that. We hand you the list itself, rebuilt every week from companies that just closed a funding round, with verified contacts for the senior people who control the new budget.

Get This Week's BioTech Leads

250+ fresh verified contacts every week, across 138 industries, from companies that just raised and have budget to spend.

250+ New verified contacts each week
7 days Every company raised within the last 7 days
138 Industries to filter and target, BioTech sectors included
Weekly A new list of funded buyers every Monday

The timing wedge

Why does B2B lead generation for BioTech work best with newly funded companies?

A fresh funding round is the clearest buying signal in BioTech sales. It means new budget, a mandate from investors to move a programme forward, and an active search for instruments, services, and vendors. BioTech leads built from companies that raised in the last 7 days reach those buyers while the spending decisions are still open.

Traditional B2B lead generation for BioTech sells you a programme. You pay a retainer, approve a script, wait through onboarding and list building, and an outsourced caller speaks to your prospect before you do. Fundraise Insider sells you the data instead, generated fresh every week from companies that just raised, with verified senior decision maker contacts attached.

That changes what your reps open on Monday morning. Instead of reading an agency report, they work a file of funded BioTech, pharmaceutical, diagnostics, and medical device companies that did not exist the week before, alongside the rest of the week's funded buyers.

It also changes the maths. There is no retainer, no seat pricing, and no minimum term, so testing this channel costs one payment rather than a quarter of budget. You can see the kind of companies that land in the file on our running list of funded BioTech startups.

Timing beats size

The value is in freshness, not in how many names a database can hold. A contact at a BioTech company is worth reaching when the business behind it has money in the bank and a stated reason to spend it this quarter.

What you get

What makes this BioTech leads list different?

Three things decide whether a lead list is worth working: when it was built, who is on it, and how far it reaches. Here is where each one stands.

Refreshed every week

A new list is generated every week, so the companies on it raised days ago rather than quarters ago. Nothing is recycled from an older file, and the batch is delivered every Monday.

Verified senior decision makers

Each company arrives with a named contact at founder, C suite, or VP level, along with a checked work email and LinkedIn profile. In BioTech that usually means the people who approve instruments, software, CRO and CDMO work, and outsourced research.

Coverage across sectors and stages

138 industries, including biotechnology, therapeutics, genomics, diagnostics, medical devices, and laboratory services, with funding stages from Angel through Series G across North America and the UK.

Inside the file

What comes with every BioTech lead record?

Every row carries nine fields, which is enough to filter the list down to BioTech accounts, write a first line that references the round, and route the contact to the right rep without extra research.

Company name
Industry
Funding stage
Funding date
Decision maker name
Job title
Verified email
LinkedIn profile
Location

The file arrives as a clean sheet you download and keep. Import it into Salesforce, HubSpot, Pipedrive, or whichever outbound sales software your team already runs.

Comparison

How does Fundraise Insider compare to other BioTech lead generation services?

Most BioTech lead generation services sell you a campaign and report on it monthly. Fundraise Insider sells a new list every week, built entirely around a funding event that just happened.

Traditional BioTech lead generation agencies Fundraise Insider
What you buy A retainer for outreach, appointment setting, and campaign management The data itself, as a sheet you download and own
Time to first send Onboarding, list building, and script approval before anything goes out Within 48 hours of signing up
Timing signal Built from industry lists and static directories holding hundreds of millions of records that are often stale or generic Recent funding is the filter. Every company raised days ago
Data freshness Sourced once at campaign setup, then ages through the engagement Generated fresh every week
Verification Mostly automated at scale Checked by hand before the list goes out
Cost model Monthly retainer, often with a minimum term or a price per meeting One time payment, no renewal
Who speaks first An outsourced caller opens the conversation with your prospect Your own reps write the first message
Who owns the data The agency keeps the list when the contract ends You download the sheet and keep it

An agency earns its place when you need people to make the calls and you have the budget to fund a long programme. A fresh weekly list of funded buyers earns its place when being early is what wins the deal. If your outbound depends on reaching a BioTech company before it picks a vendor, a list rebuilt every week beats one stored for years, which is also why our B2B contact database is rebuilt rather than warehoused.

Who uses it

Who is this BioTech leads list for?

Anyone selling into companies with fresh budget. You do not need to sell into BioTech exclusively, you just need buyers who have money and a reason to move.

Sales teams of every kind

Lab instruments, reagents, software, CRO and CDMO services, regulatory consulting, hardware, staffing, or anything else sold business to business. If your buyer signs off on new spending, a company that just raised is a better first call than one that has not.

Agencies and consultants

Marketing, development, design, recruitment, PR, regulatory, and advisory firms use the weekly list to pitch companies at the exact point where budget has landed and hiring plans are being written. That includes teams running BioTech lead generation for their own clients.

Individual reps and founders

Solo sellers and founder led sales teams get the same weekly file as everyone else, with no seat pricing and no platform to learn. Download the sheet, open your B2B sales prospecting tool, and start.

Verification

How are the BioTech leads verified before delivery?

Every weekly list is checked by hand before it goes out. We track funding announcements as they are published, confirm the company and the round, then find and review the contact details for the senior people named in the raise.

Emails and LinkedIn profiles are reviewed one by one rather than pulled in bulk. That manual pass is what keeps the weekly list current, because contact records go stale quickly in BioTech as scientists move labs and commercial leaders change roles.

Contacts are built from public funding announcements, company websites, and professional profiles where business contact details are shared publicly. Collection follows GDPR, CCPA, and the other privacy frameworks that apply to business prospecting, and the file holds business contacts in a business context rather than patient or consumer data.

Checking a record close to the moment you receive it is worth more than checking it once and storing it. That is the whole reason the list is rebuilt weekly instead of maintained as an archive. If you also sell into providers and health systems, the same weekly file supports healthcare lead generation.

Pricing

How much does B2B lead generation for BioTech cost?

Three plans, each a single payment. No subscription, no seat pricing, and no renewal date to diary.

Full Stack

The weekly list, for life

$149

One time payment

  • Weekly verified leads for life
  • 250+ new contacts each week
  • A single refreshing sheet you download weekly to keep each batch
  • Verified senior decision maker contacts
  • The historical archive is not included
Get Full Stack

The Archive

The back catalogue, delivered once

$279

One time payment

  • The full historical archive of 47,000+ funded company contacts
  • Delivered once as a CSV
  • Filter by industry, funding stage, and location
  • No weekly leads after that delivery
  • No AI prospecting prompt
Get The Archive
Most popular

Yearbook

Everything, archive and weekly

$299

One time payment

  • The same 47,000+ contact archive
  • Plus everything in Full Stack, weekly leads for life
  • Plus the AI prospecting prompt
  • 250+ new verified contacts every week
  • Only $20 more than the archive on its own
Get Yearbook

Because delivery is instant and digital, all sales are final. Full plan details are on the Fundraise Insider pricing page.

Buyer behaviour

Why do funded companies make the best contacts?

Funded companies buy because they have both budget and a deadline. A round closes with a plan attached to it, and in BioTech that plan turns into hiring, lab capacity, and vendor selection within weeks rather than quarters.

Hiring key roles and building out teams
Launching or expanding products and services
Upgrading tools, vendors, and infrastructure
Spending actively to execute a new roadmap

Each of those four signals is a reason to take a sales call. Reaching a company while all four are live is the difference between a cold email and a timely one.

Trusted by sales teams, agencies, and SaaS founders

Plaid logo, a Fundraise Insider subscriber CoDev logo, a Fundraise Insider subscriber Andiamo logo, a Fundraise Insider subscriber Reliable logo, a Fundraise Insider subscriber Packt logo, a Fundraise Insider subscriber Talent Cloud logo, a Fundraise Insider subscriber

"Everyone's using AI tools and scraping the same stale leads lists. Fundraise Insider is different. These B2B leads are curated, verified, real decision makers at companies that are actually spending. Our reply rates doubled."

Parth Mehra, Sales Director at Syncly
Parth MehraSales Director, Syncly

"Within 14 days of using Fundraise Insider's sales leads, we booked 7 demos with recently funded SaaS companies, all with $5M+ in fresh capital. Two closed within 30 days, worth $83,000 in ARR."

Jacob Huag, Founder and CEO of a B2B SaaS agency
Jacob HuagFounder and CEO, B2B SaaS Agency

"I run a lean SaaS company with no SDRs, and Fundraise Insider became my outbound secret weapon. I closed 2 deals in the first month just by emailing leads from the weekly drop."

Marcus Lee, Founder of NudgeMetrics
Marcus LeeFounder, NudgeMetrics

Questions

B2B lead generation for BioTech: frequently asked questions

Why use B2B lead generation for BioTech focused on newly funded companies?

Because funding is a timing signal you cannot get from a static directory or an industry list. A BioTech company that raised in the last 7 days has new budget, investor pressure to move a programme forward, and open decisions about which vendors to buy from. Reaching that buyer early means arriving before the shortlist is written and before most competitors know the round happened.

How is this different from a BioTech lead generation agency?

A BioTech lead generation agency sells you a programme: onboarding, list building, script approval, then outreach run by their callers on a monthly retainer. Fundraise Insider sells the data itself for a single payment, so your own reps write the first message and you keep the file forever. Most subscribers send their first sequence within 48 hours instead of waiting on a campaign launch.

What makes a good BioTech lead generation provider?

Three things: how recently the data was collected, whether the contacts are senior enough to approve a purchase, and whether a person reviewed the records before delivery. Volume claims and campaign percentages tell you very little on their own. A provider that generates a new list every week around a real funding event beats one that stores millions of aging rows.

How often is the BioTech leads list updated?

A new list is generated every week and delivered on Monday. 250+ fresh verified contacts arrive in each batch, drawn only from companies that raised within the last 7 days. Nothing is carried over from the previous week, so the file you open on Monday is genuinely new rather than a refreshed version of an old export.

How accurate are the BioTech contact details?

Every record is checked by hand before the list goes out. We confirm the company, the funding round, the named decision maker, and the work email and LinkedIn profile attached to that person. Because each weekly list is reviewed manually, contacts are verified close to the moment you receive them rather than months earlier.

What fields come with each BioTech lead record?

Each record includes company name, industry, funding stage, funding date, decision maker name, job title, verified email, LinkedIn profile, and location. That is enough to filter the list to your ideal customer profile, personalize the opening line of an email around the round, and route the contact to the right rep without extra research.

How is this different from Apollo, ZoomInfo, or Crunchbase?

Apollo, ZoomInfo, Crunchbase, and similar directories hold hundreds of millions of records collected over years, with no signal about who is buying now. Fundraise Insider works the other way around. It generates a new list every week built entirely from companies that just raised, so timing is the filter rather than something you guess at.

Can I filter BioTech leads by sector and funding stage?

Yes. The list arrives as a spreadsheet with industry, funding stage, funding date, and location as columns, covering 138 industries and stages from Angel through Series G across North America and the UK. Filter it to biotechnology, therapeutics, genomics, diagnostics, medical devices, or laboratory services, then export only the rows your reps will work.

How are the leads delivered and can I use them in my CRM?

Leads arrive as a sheet you download and keep. There is no platform to log into and no integration to configure, so you can import the file straight into Salesforce, HubSpot, Pipedrive, or any outreach tool your team already runs. Contacts are built from public funding announcements and professional profiles, in line with GDPR and CCPA.

How much does lead generation for a BioTech company cost?

There are three plans, each a single one time payment with no subscription. Full Stack is $149 for weekly verified leads for life. The Archive is $279 for the historical file of 47,000+ funded company contacts, delivered once. Yearbook is $299 and includes both plus the AI prospecting prompt, which is $20 more than the archive alone.

Start Monday with BioTech leads that did not exist last week

250+ verified contacts from companies that raised in the last 7 days, delivered every week, for a single payment.

Get This Week's BioTech Leads

Business Specific Leads

Fresh Leads Delivered Every Monday Morning.